Perceptive Advisors

General contacts

Investor type

PE / VC

Founded

1999

AUM

$9 700 M

Location

New York, New York, United States

Investment Ticket

$10-50 m

Investment Stage

Series B Series A Seed Late Stage (Series C+)

Region of investment

Europe North America Asia

Investor profile last updated: 16 August, 2026

Profile

Perceptive Advisors is a life sciences-focused investment firm based in New York City, founded in 1999. The firm was established to identify and support promising innovations in the healthcare field. The team consists of individuals with a strong background in both scientific and investment expertise, which enables them to assess and invest in breakthrough healthcare technologies. The firm stands out for its dedication to integrating scientific insight with investment acumen in their approach to funding life sciences advancements.

Perceptive Advisors invests primarily in the healthcare sector, with particular interest in biopharmaceuticals and medical technology. Their investment strategy spans both private and public companies, and they consider a variety of capital structures. While specific check sizes are not detailed, the stages range from early to late, covering various phases of company growth. Notable funds include the Perceptive Life Sciences Fund, designed to encompass diverse investments within this field.

The firm has an impressive portfolio, which includes companies like Achilles Therapeutics - focused on cancer immunotherapies, AEGEA Medical - working on medical vapor ablation technology, Affimed - developing cancer immunotherapies, Agile Therapeutics - specializing in women's healthcare products, and Athenex - dedicated to cancer therapy development. They are recognized for their role in advancing products with substantial potential for healthcare improvements.

Industry

Robotics AI MedTech Life Sciences HealthTech Biotechnology Healthcare Services Medical Devices Other Pharmaceuticals

Perceptive Advisors Funds

Name	Type	Industry	Stage	Region	Size	AUM	Launch date
Perceptive Xontogeny Venture Fund II, LP	Venture Capital (VC)	Biotechnology Healthcare Services	Pre-seed Seed Series A	North America South America Europe Middle East Africa Asia Australia and others	$5-10 m	$515 M	May 2021
Perceptive Credit Opportunities Fund III	Venture Capital (VC)	Biotechnology Healthcare Services	Pre-seed Seed Series A	North America South America Europe Middle East Africa Asia Australia and others	$5-10 m	$1000 M	December 2020
Perceptive Xontogeny Venture Fund	Venture Capital (VC)	Biotechnology Healthcare Services	Pre-seed Seed Series A	North America South America Europe Middle East Africa Asia Australia and others	$5-10 m	$210 M	December 2019

Contacts

Name

Title

Social Networks

Fred Callori Partner, Venture (PXV Fund)

Partner, Venture (PXV Fund)

f•••@•••

Craig Yeshion Managing Director

Managing Director

c•••@•••

Upgrade to see contacts

TM72V5fASZypiHmu TM72V5fASZypiHmu

TM72V5fASZypiHmu

[email protected]

TM72V5fASZypiHmu TM72V5fASZypiHmu

TM72V5fASZypiHmu

[email protected]

TM72V5fASZypiHmu TM72V5fASZypiHmu

TM72V5fASZypiHmu

[email protected]

Investment-team contacts for Perceptive Advisors — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Perceptive Advisors

Is Perceptive Advisors a venture capital or private equity firm?

Perceptive Advisors is a venture capital and private equity firm. It backs companies at Series B, Series A, Seed and Late Stage (Series C+), writing tickets of $10-50 m.

Where is Perceptive Advisors located?

Perceptive Advisors is located in New York, New York, United States.

When was Perceptive Advisors founded?

Perceptive Advisors was founded in 1999.

What sectors and industries does Perceptive Advisors invest in?

Perceptive Advisors invests in companies and startups in Robotics, AI, MedTech, Life Sciences, HealthTech, Biotechnology, Healthcare Services, Medical Devices, Other, Pharmaceuticals.

What is Perceptive Advisors geographical focus of investments?

Perceptive Advisors invests in companies and startups in Europe, North America, Asia.

At what stages of companies and startups does Perceptive Advisors typically invest in?

Perceptive Advisors invests in companies and startups at Series B, Series A, Seed, Late Stage (Series C+).

What is the usual amount of Perceptive Advisors investment?

Perceptive Advisors usually invests $10-50 m on average.

What is the amount of assets of under management (AUM) for Perceptive Advisors?

Perceptive Advisors has around $9 700m assets under management.

When was Perceptive Advisors last fund created?

Perceptive Advisors last fund was created/launched in 2021-05-12

What are the contacts of Perceptive Advisors?

Perceptive Advisors can be reached through its website perceptivelife.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Perceptive Advisors — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access Perceptive Advisors data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Perceptive Advisors directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the Perceptive Advisors profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.